Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma

Clinical trial NCT07257510 · RECRUITING

Trial details

NCT number: NCT07257510
Sponsor: Peking University Third Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Mantle Cell Lymphoma (MCL)POZ

Start date: 2025-08-01
Primary completion: 2028-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.